NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

Arima, K., Uéda, Kenji, Sunohara, Nobuhiko, Arakawa, Kenji, Hirai, Shigeo, Nakamura, Minako, Tonozuka-Uehara, Haruko, Kawai, Mitsuru·1998·Acta Neuropathologica
DOI 10.1007/s004010050917

Cited by (239)

Items 201–239 of 239

  1. Chapter 7 Ubiquitinopathies
    Dickson, Dennis W. · 2007 · Blue Books of Neurology
  2. Case Report: Synucleinopathy Associated With Phalaris Neurotoxicity in Sheep
    Mourad Tayebi, Pedro Pinczowski, Umma Habiba, Rizwan Hasan Khan, Monique Antoinette David, Brian Alan Summers · 2021 · Frontiers in Veterinary Science
  3. Sensitized Emission Imaging Allows Nanoscale Surface Polarity Mapping of α-Synuclein Amyloid Fibrils
    Jaladhar Mahato, Rajat Mukherjee, Abhik Bose, Surabhi Mehra, Laxmikant G. Gadhe, Samir Kumar Maji, Arindam Chowdhury · 2023 · ACS Chemical Neuroscience
  4. Protein Misfolding, Neurodegeneration and Tau
    Pierfausto Seneci · 2015 · Elsevier eBooks
  5. Neuropathology of Movement Disorders
    K. A. Jellinger · 2011 · Elsevier eBooks
  6. Neuropathology and staging of parkinson’s disease
    Dennis W. Dickson · 2007
  7. α-Synuclein/NACP and neurodegeneration
    Seigo Tanaka, Masanori Takehashi, Naomi Matoh, Kunihiro Ueda · 2001 · Birkhäuser Basel eBooks
  8. Etiology, Pathology, and Pathogenesis
    Felix Geser, K. A. Jellinger, Martin Köllensperger, Nadia Stefanova, Gregor Karl Wenning · 2009 · Blue books of neurology
  9. Antiepileptic effects of levetiracetam related to the regulation of cell cycle reentry in the parietal cortex of EL mouse brain
    Yoshiya L. Murashima, Mitsunobu Yoshii · 2010 · Epilepsy & Seizure
  10. Neuropathology of Ataxias
    Mitsunori Yamada · 2021 · Springer eBooks
  11. α-Synuclein, synphilin-1 and inclusion body formation in α-synucleinopathies
    Koichi Wakabayashi, Hitoshi Takahashi · 2003 · International Congress Series
  12. Characterisation of embryonic ventral mesencephalon grafts in a rat model of Parkinson’s disease
    Marija Fjodorova · 2013 · ORCA Online Research @Cardiff (Cardiff University)
  13. Encephalomyelitis, brain tumors, neuromuscular diseases and miscellaneous disorders
    Yoichi Nakazato, Kazuo Nagashima · 2000 · Neuropathology
  14. Tau and α-Synuclein in Neurodegenerative Diseases
    Benoit I. Giasson, Clare Wilson, John Q. Trojanowski, Virginia M.‐Y. Lee · 2001 · Humana Press eBooks
  15. Pathogenesis of dementia: updating the role of synuclein pathology in sporadic and hereditary Alzheimer’s disease
    John E. Duda, Virginia M.‐Y. Lee, John Q. Trojanowski · 2001 · Birkhäuser Basel eBooks
  16. Chapter 3 Multiple System Atrophy
    Felix Geser, Christoph Globas, Ludger J. Schöls, Gregor Karl Wenning · 2007 · Blue books of neurology
  17. Parkinson-Krankheit: Pathophysiologie und pathogenetische Faktoren
    K. A. Jellinger · 1999 · Springer eBooks
  18. Brain Dysfunction Associated with Amyloid Fibrils and Other Aggregated Proteins
    Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini, Gianluigi Forloni · 2005 · Wiley eBooks
  19. Alzheimer's disease and dementia with Lewy bodies: Special focus on the role of serpins
    Henrietta M. Nielsen · 2007 · Lund University Publications (Lund University)
  20. Protein Aggregates in Neurodegenerative Disorders
    Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini, Gianluigi Forloni · 2008 · Wiley eBooks
  21. Widespread expression of α-synuclein in neuronal cytoplasm and glial cells in the central and peripheral nervous systems in human
    Fumiaki Mori, Kunikazu Tanji, Makoto Yoshimoto, Hitoshi Takahashi, Koichi Wakabayashi · 2003 · International Congress Series
  22. Estudios de asociación genética y detección de mutaciones en pacientes con enfermedad de Parkinson. Comparación genético-clínica entre los casos esporádicos y familiares.
    Esteban Muñoz García · 2001 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  23. SIRT1Protectsagainst!-SynucleinAggregationby ActivatingMolecularChaperones
    Gizem Dönmez · 2012
  24. Utilizing Galectin 3 as a Marker of Ruptured Vesicles In Vivo
    Jonathan London · 2015 · Loyola eCommons (Loyola University of Chicago)
  25. α-Synuclein fibrillogenesis as target for drug development
    Martin Citron, Linda Owers Narhi, Jette Wypych, Jean‐Claude Louis, Anja Leona Biere · 2001 · Birkhäuser Basel eBooks
  26. Studies on DNA Helicity, Stability and alpha-Synuclein-DNA Interactions in relevance to Parkinson's Disease
    L. Hegde Muralidhar · 2005 · CFTRI Institutional Repository
  27. Synucleinopathies
    Irina I. Alafuzoff, Maria Pikkarainen, Laura Parkkinen · 2014 · Cambridge University Press eBooks
  28. Multidisciplinary analysis of the energetics and mechanism of assembly of amyloid oligomeric precursors
    David Ruzafa · 2014 · Institutional Repository of the University of Granada (University of Granada)
  29. Alpha-synuclein as a regulator of synaptic signalling
    Anssi Pelkonen · 2013 · UEF eRepo (University of Eastern Finland)
  30. PAR2 activation increases α-synuclein expression, aggregation and phosphorylation in human oligodendrocytes with emphasis on pathophysiology of Multiple System Atrophy (MSA)
    Zahra Shams Shoaei · 2018 · TSpace (University of Toronto)
  31. The Immune Response in Parkinson's Disease
    Arman Lira · 2014 · uO Research (University of Ottawa)
  32. Faculty Opinions recommendation of Cryo-EM structure of alpha-synuclein fibrils.
    Sjors H. W. Scheres · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  33. 統一多系統萎縮症評価尺度 UMSARSの邦訳とその信頼性・妥当性
    学 大友, 尾方克久, 幹也 鈴木, 聡子 宮武, 岡橋里美, 仁志 望月, 拓久 田村, 充 川井 · 2008 · 医療
  34. Additional file 1 of Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
    Hiroaki Sekiya, Asato Tsuji, Hashimoto, Yuki, Mariko Takata, Shunsuke Koga, Katsuya Nishida, Naonobu Futamura, Michi Kawamoto, Nobuo Kohara, Dennis W. Dickson et al. · 2022 · Figshare
  35. Additional file 1 of Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice
    Tatsuhiko Sano, Tetsuya Nagata, Satoe Ebihara, Kie Yoshida‐Tanaka, Ayako Nakamura, Asuka Sasaki, Aki Shimozawa, Mochizuki, Hideki, Toshiki Uchihara, Masato Hasegawa et al. · 2024 · Figshare
  36. Modélisation et recherche de stratégies expérimentales dans l’atrophie multisystématisée
    Paul A. Guerin · 2018
  37. Proteomics identified carboxypeptidase E as a novel biomarker for synucleinopathies
    Mingyue Luan, Luhua Wei, Jing Chen, Fan Li, Kai Li, Wei Sun, Fuze Zheng, Li Zhu, Zhaoxia Wang, Wei Wu et al. · 2026 · npj Parkinson s Disease
  38. Untitled work
    MP Mattson · 1999 · 10.1002/(sici)1097-4547(19991001)58:1
  39. Untitled work
    Goodrum · 2000 · 10.1002/(sici)1097-4547(20000215)59:4